Cargando…
Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?
The COVID-19 has plunged the world into a pandemic that affected millions. The continually emerging new variants of concern raise the question as to whether the existing vaccines will continue to provide sufficient protection for individuals from SARS-CoV-2 during natural infection. This narrative r...
Autores principales: | He, Xuesong, Zeng, Xiao Xue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979261/ https://www.ncbi.nlm.nih.gov/pubmed/35386853 http://dx.doi.org/10.2147/DDDT.S347297 |
Ejemplares similares
-
A CRISPR-Cas Cure for HIV/AIDS
por: Hussein, Mouraya, et al.
Publicado: (2023) -
Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas
por: Yang, Yu-Chan, et al.
Publicado: (2021) -
Exploiting the CRISPR‐Cas9 gene‐editing system for human cancers and immunotherapy
por: Afolabi, Lukman O, et al.
Publicado: (2021) -
CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy
por: Chen, Chen, et al.
Publicado: (2023) -
Advances of CRISPR-Cas13 system in COVID-19 diagnosis and treatment
por: Zhou, Qianqian, et al.
Publicado: (2022)